-
Is information on breast self-exams (BSEs) included in your care of women? Findings from a 2009 study indicate that a brief intervention program based on a single counseling session and two follow-up phone calls significantly increased the number of women correctly performing such exams.
-
Plan to get the latest information on family planning issues at three fall conferences. All three events will cover cutting-edge material on contraceptive practices and will offer continuing education credits.
-
When it comes to emergency contraception (EC), placement of a Copper T 380A intrauterine device [(IUD), ParaGard, Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals; Pomona, NY] offers excellent protection against unwanted pregnancy, as well as long-term contraception. What are some of the roadblocks that may hinder its use?
-
The Food and Drug Administration (FDA) has approved two new tests for human papillomavirus (HPV). How does the addition of these tests affect current practice?
-
During his 2008 campaign and in the budget framework that President Obama sent to Congress late in February, he signaled his support for a U-turn in federal policy to prevent pregnancy and sexually transmitted infections (STIs) among American youth.
-
Female-controlled prevention options are set to expand with the Food and Drug Administration (FDA) March 2009 approval of the second generation of the female condom manufactured by the Female Health Co.
-
If your practice includes care of pregnant women, be sure to review just-issued interim guidance from the Centers for Disease Control and Prevention (CDC) in regard to swine influenza A (H1N1) virus infection.
-
Women who have been searching for the Today contraceptive sponge on pharmacy shelves can stop hunting: Mayer Laboratories now serves as the U.S. distributor for the over-the-counter contraceptive.
-
The Food and Drug Administration (FDA) is complying with a federal judge's instruction and is directing the manufacturers of the dedicated emergency contraceptive pill Plan B to make the drug available to 17-year-olds without prescription.
-
How is your facility coping with the current economic downturn? Look to the July issue of Contraceptive Technology Update for special focus articles that will report on such up-to-the-moment items as these:
